These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 15803155

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E, Zhang C, Su Y, Cheng T, Shi C.
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [Abstract] [Full Text] [Related]

  • 24. The polyamine transport system as a target for anticancer drug development.
    Palmer AJ, Wallace HM.
    Amino Acids; 2010 Feb; 38(2):415-22. PubMed ID: 19956998
    [Abstract] [Full Text] [Related]

  • 25. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A, Scheiber J, Glick M, Davies JW, Azzaoui K, Hamon J, Urban L, Whitebread S, Jenkins JL.
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Discovery of new anti-cancer agents.
    Lobbezoo MW, Krul MR, Pinedo HM.
    Forum (Genova); 1999 Jun; 9(3 Suppl 3):47-53. PubMed ID: 10607846
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development.
    Hermiston TW, Kirn DH.
    Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I.
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [Abstract] [Full Text] [Related]

  • 34. Druggable targets and targeted drugs: enhancing the development of new therapeutics.
    Billingsley ML.
    Pharmacology; 2008 May; 82(4):239-44. PubMed ID: 18802381
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM, Bennett CF.
    Oncogene; 2003 Dec 08; 22(56):9087-96. PubMed ID: 14663487
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The role of chemical sciences in 21st century cancer drug discovery.
    Neidle S, Thurston DE.
    Discov Med; 2005 Oct 08; 5(29):450-4. PubMed ID: 20704841
    [Abstract] [Full Text] [Related]

  • 40. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
    Bodovitz S.
    IDrugs; 2010 Jan 08; 13(1):23-5. PubMed ID: 20024843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.